Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003

• Status: Completed
• Trial end date: 2008-10-15
• Target enrollment: 0
• Participant gender: Female

Summary

ZPU-003 EXT is a 2-year extension study of ZPU-003 (NCT00882258) to determine the continued safety and efficacy of Proellex in women who have previously completed the double-blind portion of the study.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Repros Therapeutics Inc.

Criteria

Inclusion Criteria:

• Completed the ZPU 003 study and met the inclusion/exclusion criteria of that study.

Exclusion Criteria:

• Low or high grade cervical dysplasia, as determined by Papanicolaou (PAP) smear.

• Pregnant or breastfeeding.